Vital Art and Science Announces License Agreement with Genentech for Its mVT® Service

DALLAS--(BUSINESS WIRE)--Vital Art and Science, LLC today announced that it has signed a license agreement with Genentech, a member of the Roche Group, for the use of Vital Art and Science’s mVT® App service in Genentech’s ophthalmology clinical studies. Under the terms of the agreement, Genentech intends to use the App service to enhance patient experience, improve the effectiveness of patient‘s interactions with health care providers and apply the data collected through the App service to imp

Full Story →